How to prepare your practice for Stark II compliance
As of January 4, the final Stark II rules became effective. These federalregulations will have a profound effect on the relationship between urologypractices and the Medicare and Medicaid programs. Their impact extends farbeyond lithotripsy, which has been the primary concern of many urologists,to virtually every aspect of their practices. Practices that have not conformedto the requirements of these new regulations are exposed to financial penaltiesand other severe sanctions.
Long-term QUILT-3.032 findings show durable responses with Anktiva plus BCG in BCG-unresponsive NMIBC, with an estimated 84.2% cystectomy-free survival at 3 years.
Sandip M. Prasad, MD, MPhil, discusses the safety profile of mitomycin intravesical solution, including common adverse events and patient counseling during chemoablation for NMIBC.
Sandip M. Prasad, MD, MPhil, discusses 3-year ENVISION trial data showing durable responses with mitomycin intravesical solution for recurrent LG-IR-NMIBC.
Armine K. Smith, MD, discusses sexual health counseling, sex-specific considerations, and organ-preserving approaches for patients undergoing radical cystectomy.